new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)





Similar
Filing Names

Targacept Inc
Targacept Inc_20100114
  

Targacept Inc patents

Recent patent applications related to Targacept Inc. Targacept Inc is listed as an Agent/Assignee. Note: Targacept Inc may have other listings under different names/spellings. We're not affiliated with Targacept Inc, we're just tracking patents.

ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "T" | Targacept Inc-related inventors




Date Targacept Inc patents (updated weekly) - BOOKMARK this page
02/18/16Synthesis and novel salt forms of (r)-5-((e)-2-pyrrolidin-3ylvinyl)pyrimidine
01/14/16Nicotinic receptor non-competitive antagonists
11/05/15Hydroxybenzoate salts of metanicotine compounds
06/18/15Arylvinylazacycloalkane compounds and methods of preparation and use thereof
04/30/15Azetidinyloxy-, pyrrolidinyloxy-, and piperidinyloxy-substituted metanicotines as neuronal nicotinic acetylcholine receptor ligands
04/16/15Preparation and therapeutic applications of (2s,3r)-n-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide
03/19/15Sub-type selective amides of diazabicycloalkanes
02/12/15(2s,3r)-n-2-3-pyridinylmethyl-1-azabicyclo 2.2.2 oct-3-yl benzofuran-2-carboxamide, novel salt forms, and methods of use thereof
01/29/15Diazabicyclo[3.3.1]nonanes, methods of synthesis, and uses thereof
09/25/14Nicotinic receptor non-competitive antagonists
09/04/141,4-diazabicyclo[3.2.2]nonanes as neuronal nicotinic acetylcholine receptor ligands
08/21/14Treatment wth alphat selective ligands
07/10/14Exo-s-mecamylamine formulation and use in treatment
06/12/14Preparation and therapeutic applications of (2s, 3r)-n-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide
04/17/14Arylvinylazacycloalkane compounds and methods of preparation and use thereof
03/06/14Synthesis and novel salt forms of (r)-5-((e)-2-pyrrolidin-3ylvinyl)pyrimidine
02/06/14Hydroxybenzoate salts of metanicotine compounds
01/23/14Treatment of cognitive dysfunction in schizophrenia
11/21/13Chemical entity search, for a collaboration and content management system
11/21/13Novel polymorph forms of (2s)-(4e)-n-methyl-5-[3-(5-isopropoxypyridin)yl]-4-penten-2-amine
09/26/13Method of treating bladder disorders
09/12/13Arylvinylazacycloalkane compounds for constipation
01/03/13Nicotinic acetylcholine receptor sub-type selective amides of diazabicycloalkanes
12/06/123,6-diazabicyclo[3.1.1]heptanes as neuronal nicotinic acetycholine receptor ligands
11/15/12Nicotinic acetylcholine receptor sub-type selective amides of diazabicycloalkanes
07/26/12Exo-s-mecamylamine method, use, and compound for treatment
06/21/12Reversal of l-dopa-induced dyskinesia by neuronal nicotinic receptor ligands
05/31/123-substituted-2-(arlyalkyl)-1-azabicycloalkanes and methods of use thereof
05/24/12(2s,3r)-n-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofurn-2-carboxamide, novel salt forms, and methods of use thereof
05/10/12Combination therapy for the management of hypertension
03/01/12Fused benzoazepines as neuronal nicotinic acetylcholine receptor ligands
01/19/12Synthesis and novel salt forms of (r)-3-((e)-pyrrolidin-3-yl)vinyl)-5-tetrahydropyran-4-yloxy)pyridine
11/17/11Synthesis and novel salt forms of (r)-5-((e)-2-pyrrolidin-3ylvinyl)pyrimidine
11/03/11Novel compounds
10/27/11Treatment with alpha7 selective ligands
10/27/11Amides of diazabicyclooctanes and uses thereof
10/27/11(2s, 3r)-n-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-2-carboxamide, novel salt forms, and methods of use thereof
10/20/11Preparation and therapeutic applications of (2s,3r)-n-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide
10/20/11Derivatives of oxabispidine as neuronal nicotinic acetylcholine receptor ligands
06/23/11Arylvinylazacycloalkane compounds and methods of preparation and use thereof
05/26/11Treatment with alpha 7-selective ligands
05/19/11Preparation and enantiomeric separation of 7-(3-pyridinyl)-1,7-diazaspiro[4.4]nonane and novel salt forms of the racemate and enantiomers
05/05/11N-aryl diazaspirocyclic compounds and methods of preparation and use thereof
03/24/11Sub-type selective amides of diazabicycloalkanes
03/24/113-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
03/24/113-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
03/24/113-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
03/10/11Alpha 7 nicotinic agonists and antipsychotics
03/10/11Prophylaxis and treatment of infectious diseases
11/11/10Exo-s-mecamylamine formulation and use in treatment
10/21/10Arylvinylazacycloalkane compounds and methods of preparation and use thereof
09/30/10Novel salt forms of (2s)-(4e)-n-methyl-5-[3-(5-isopropoxypyridin)yl]-4-penten 2-amine
09/23/10N-aryl azaspiroalkene and azaspiroalkane compounds and methods of preparation and use thereof
09/23/103-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
09/02/10Compounds capable of activating cholinergic receptors
08/12/10Compounds capable of activating cholinergic receptors
08/05/10Heteroaryl-substituted diazatricycloalkanes and methods of use thereof
07/15/10Pharmaceutical compositions and methods for relieving pain and treating central nervous system disorders
07/08/10Sub-type selective amides of diazabicycloalkanes
07/08/10Sub-type selective azabicycloalkane derivatives
06/24/10Compounds capable of activating cholinergic receptors
06/17/10Pharmaceutical compositions and methods for relieving pain and treating central nervous system disorders
06/17/103-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
06/17/103-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
06/10/10Heterocyclic-carbonyl-diazabicycloalkanes as modulators of the neuronal nicotinic acetylcholine alpha 4 beta 2, subtype receptor for the treatment of cns related disorders
Patent Packs
05/13/10Compounds capable of activating cholinergic receptors
02/04/10Intranasal, buccal, and sublingual administration of metanicotine analogs
01/14/10Arylvinylazacycloalkane compounds and methods of preparation and use thereof
03/05/09Hydroxybenzoate salts of metanicotine compounds
01/14/10Arylvinylazacycloalkane compounds and methods of preparation and use thereof







ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Targacept Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Targacept Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';